CompletedPHASE2, PHASE3NCT00237016
Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
Studying Relapsing fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical Corps, Israel Defense Force
- Principal Investigator
- Tal Hasin, MD, MDMedical corps, Israel Defence Forces
- Intervention
- doxycycline treatment(drug)
- Enrollment
- 140 enrolled
- Eligibility
- All sexes
- Timeline
- 2002 – 2003
Study locations (1)
- Israel Defence Forces, Tel Litwinsky, Israel
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00237016 on ClinicalTrials.gov